Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Details for Australian Patent Application No. 2008209697 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Ormerod, Dominic John; Horvath, Andras; Depre, Dominique Paul Michel

Agent Shelston IP

Pub. Number AU-A-2008209697

PCT Pub. Number WO2008/092955

Priority 07101571.3 01.02.07 EP

Filing date 1 February 2008

Wipo publication date 7 August 2008

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07C 61/06 (2006.01) Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings

C07C 69/74 (2006.01) Esters of carboxylic acids

C07C 233/58 (2006.01) Carboxylic acid amides

C07D 311/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/092955 Priority application(s): WO2008/092955

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209700-A gateway device

2008209696-Polymorphic forms of a macrocyclic inhibitor of HCV